Sanara Medtech

SMTI · NASDAQ

$33.14+$0.00 (+0.00%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $33.14

Latest news

Press releaseSep 11, 1:05 PM ETPRNewswire
Are SMTI, LAB, ATKR, VAL Obtaining Fair Deals for their Shareholders?
Press releaseSep 10, 4:09 PM ETBusiness Wire
Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc. - SMTI
Press releaseAug 29, 6:34 AM ETBusiness Wire
SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders
Press releaseAug 11, 4:10 PM ETGlobe Newswire
Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited)
Press releaseAug 6, 3:48 PM ETPRNewswire
Are MKTX, SMTI, FBRX, LXFR Obtaining Fair Deals for their Shareholders?
Press releaseAug 5, 1:26 PM ETPRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--FBRX, LXFR, SMTI, and MKTX
Press releaseAug 3, 7:38 PM ETPRNewswire
Are MKTX, SMTI, LPSN Obtaining Fair Deals for their Shareholders?
Press releaseAug 3, 4:19 PM ETBusiness Wire
Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc. - SMTI
Press releaseJul 30, 1:16 PM ETPRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sanara MedTech Inc. (NASDAQ: SMTI)
Press releaseJul 30, 3:59 AM ETPRNewswire
Shareholder Alert: Ademi LLP investigates whether Sanara MedTech Inc. is obtaining a Fair Price for Public Shareholders
Press releaseJul 29, 7:00 PM ETBusiness Wire
SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders
Press releaseJul 29, 4:07 PM ETGlobe Newswire
MIMEDX Announces Second Quarter 2026 Operating & Financial Results
Press releaseJul 29, 4:01 PM ETGlobe Newswire
MIMEDX to Acquire Sanara MedTech
Press releaseMay 19, 5:49 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
Press releaseMay 14, 8:15 PM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
Press releaseMay 12, 5:25 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
NewsMay 12, 1:06 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsMay 12, 8:23 AM ET
Transcript: Sanara MedTech Q1 2026 Earnings Conference Call
NewsMay 11, 5:12 PM ET
Sanara MedTech Q1 EPS $0.05 Beats $(0.04) Estimate, Sales $27.799M Beat $26.800M Estimate
Press releaseMay 11, 4:50 PM ETGlobe Newswire
Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)
Press releaseMay 7, 8:57 PM ETGlobe Newswire
SMTI Investors Have Opportunity to Join Sanara MedTech Inc. Fraud Investigation with the Schall Law Firm
Press releaseApr 30, 9:42 PM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
Press releaseApr 28, 4:32 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
Press releaseApr 14, 7:30 AM ETGlobe Newswire
Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026
NewsMar 24, 10:16 AM ET
CORRECTION: Sanara MedTech Q4 Adj. EPS $0.09 Misses $0.11 Estimate, Sales $27.546M Beat $27.400M Estimate (Adj EPS Excludes Asset impairment Charges $0.22/Share)
NewsMar 24, 7:11 AM ET
Earnings Scheduled For March 24, 2026
Press releaseMar 24, 7:00 AM ETGlobe Newswire
Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial Guidance
Press releaseMar 11, 7:30 AM ETGlobe Newswire
Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds
Press releaseMar 3, 7:30 AM ETGlobe Newswire
Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026
Press releaseFeb 17, 7:30 AM ETGlobe Newswire
Sanara MedTech Inc. to Participate in the TD Cowen 46th Annual Health Care Conference on March 3rd
Press releaseJan 23, 7:30 AM ETGlobe Newswire
Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance
Press releaseNov 24, 1:59 PM ETGlobe Newswire
INVESTOR ALERT: Investigation of Sanara MedTech Inc. (SMTI) Announced by Holzer & Holzer, LLC
Press releaseNov 20, 4:20 PM ETBusiness Wire
Securities Fraud Investigation Into Sanara MedTech Inc. (SMTI) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Press releaseNov 20, 9:00 AM ETBusiness Wire
Sanara MedTech Inc. (SMTI) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Press releaseNov 19, 5:04 PM ETBusiness Wire
Securities Fraud Investigation Into Sanara MedTech Inc. (SMTI) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
NewsNov 12, 12:05 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsNov 12, 6:11 AM ET
Earnings Scheduled For November 12, 2025
Press releaseNov 11, 4:05 PM ETGlobe Newswire
Sanara MedTech Inc. Announces Strategic Realignment to Focus on Surgical Business
NewsMar 26, 2:00 PM ET
Where Sanara MedTech Stands With Analysts

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Are SMTI, LAB, ATKR, VAL Obtaining Fair Deals for their Shareholders?

Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc. - SMTI

SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders

Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited)

Are MKTX, SMTI, FBRX, LXFR Obtaining Fair Deals for their Shareholders?

$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--FBRX, LXFR, SMTI, and MKTX

Are MKTX, SMTI, LPSN Obtaining Fair Deals for their Shareholders?

Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc. - SMTI

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sanara MedTech Inc. (NASDAQ: SMTI)

Shareholder Alert: Ademi LLP investigates whether Sanara MedTech Inc. is obtaining a Fair Price for Public Shareholders

SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

MIMEDX to Acquire Sanara MedTech

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI

12 Health Care Stocks Moving In Tuesday's Intraday Session

Transcript: Sanara MedTech Q1 2026 Earnings Conference Call

Sanara MedTech Q1 EPS $0.05 Beats $(0.04) Estimate, Sales $27.799M Beat $26.800M Estimate

Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)

SMTI Investors Have Opportunity to Join Sanara MedTech Inc. Fraud Investigation with the Schall Law Firm

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI

Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026

CORRECTION: Sanara MedTech Q4 Adj. EPS $0.09 Misses $0.11 Estimate, Sales $27.546M Beat $27.400M Estimate (Adj EPS Excludes Asset impairment Charges $0.22/Share)

Earnings Scheduled For March 24, 2026

Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial Guidance

Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds

Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026

Sanara MedTech Inc. to Participate in the TD Cowen 46th Annual Health Care Conference on March 3rd

Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance

INVESTOR ALERT: Investigation of Sanara MedTech Inc. (SMTI) Announced by Holzer & Holzer, LLC

Securities Fraud Investigation Into Sanara MedTech Inc. (SMTI) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

Sanara MedTech Inc. (SMTI) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Securities Fraud Investigation Into Sanara MedTech Inc. (SMTI) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

12 Health Care Stocks Moving In Wednesday's Intraday Session

Earnings Scheduled For November 12, 2025

Sanara MedTech Inc. Announces Strategic Realignment to Focus on Surgical Business

Where Sanara MedTech Stands With Analysts